All News

When experiencing loss, always look forward and have hope.

Research has found simple hysterectomy to not be inferior to radical hysterectomy among patients with low-risk cervical cancer.

The novel treatment, zanidatamab, has been submitted to the FDA via a Biologics License Application for patients with HER2-positive biliary tract cancer.

After five years of being cancer-free, my oncologist said I'm graduated and can live my life freely.

The Food and Drug Administration approved the CAR-T cell therapy, Carvykti, for previously treated patients with multiple myeloma.

When I was diagnosed with breast cancer in July 2022, I of course turned to my art.

Even after surgery and chemotherapy, I make sure to shine through cancer and any fear that stares at me.

Cancer is an emotionless assassin that can attack us and the ones we love most.

Undergoing cancer treatment is like pulling weeds — we hope we got the last of it and it does not return, but we can never be sure.

Certain levels of immune cells in the breast tissue were associated with better survival in triple-negative breast cancer, according to recent research.

Enhertu has been approved by the FDA for certain patients with unresectable or metastatic HER2-positive solid tumors.

Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.

When my doctor told me, "I want to talk to you about something," I suddenly felt worried — thankfully it was good news.

From WWE champion Roman Reigns sharing about his leukemia status to Arizona rep. Raúl Grijalva announcing diagnosis, here’s what’s going on in the oncology space this week.

The Food and Drug Administration approved Abecma for adults with relapsed or refractory multiple myeloma who have received two or more previous lines of therapy.

When I was my husband's caregiver, I tried to make things comfortable, but I'm not sure if the drugs and bedpans could ever make it right.

Treatment with immune checkpoint inhibitors has improved survival outcomes for patients with metastatic bladder cancer, compared with chemotherapy.

An expert explains how gene-expression profile testing can inform treatment decisions for patients with squamous cell carcinoma.

Before cancer, I started to lose myself, but cancer taught me that loving myself isn't selfish.

Camille Wahl has had osteosarcoma since she was 10, and she found a tireless advocate in her mother.

My plastic surgeon helped me accept my new face after basal cell carcinoma left a hole in my face.

There is no difference in treatment for non-secretory multiple myeloma and multiple myeloma, an expert told CURE®.

A vaccine developer discusses a cancer vaccine that has been shown to potentially boost long-term overall postsurgical survival.

When I wore my street clothes in the hospital instead of a gown, I felt more like a person than a patient with cancer.

Childbirth rates have been reduced by 22% in women with MPNs, compared with women without MPNs, researchers found.

Of everything I've ever done, I wonder how my multiple myeloma came to be.

Recent research has shown encouraging results for older patients with classical Hodgkin lymphoma treated with Adcetris plus chemotherapy or Opdivo.

The Food and Drug Administration granted UTD1 an orphan drug designation to treat brain metastases in patients with breast cancer.

Questions about cancer can often be confusing and frustrating.

Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.